Work

IMMU-130, a unique antibody-drug conjugate (ADC) of SN-38 targeting CEACAM5 antigen: Preclinical basis for clinical activity in metastatic colorectal cancer (mCRC).

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.3_suppl.625

Authors: Serengulam V. Govindan, Thomas M. Cardillo, Edmund A. Rossi, William J. McBride, Robert M. Sharkey, David M. Goldenberg

Institutions: Immunomedics (United States), Center for Molecular Medicine and Immunology

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2342116486

Cites:

Cited by: 7

Related to: 10